Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of “Moderate Buy” by Analysts

Shares of Omada Health, Inc. (NASDAQ:OMDA) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $22.9091.

OMDA has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price target on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Morgan Stanley decreased their price objective on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Friday, March 6th. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 target price on shares of Omada Health in a report on Friday, May 8th. Wells Fargo & Company boosted their target price on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Finally, Evercore reaffirmed an “outperform” rating and issued a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th.

Omada Health Stock Performance

Shares of OMDA stock opened at $17.33 on Tuesday. The stock’s 50 day simple moving average is $15.45 and its 200 day simple moving average is $14.80. Omada Health has a twelve month low of $10.28 and a twelve month high of $26.92. The company has a market capitalization of $1.03 billion and a price-to-earnings ratio of -64.19.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. On average, analysts forecast that Omada Health will post -0.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, President Wei-Li Shao sold 2,829 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $12.71, for a total transaction of $35,956.59. Following the completion of the sale, the president owned 328,850 shares in the company, valued at $4,179,683.50. This represents a 0.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 6.38% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Raymond James Financial Inc. bought a new stake in shares of Omada Health in the second quarter valued at approximately $32,000. Bellevue Group AG grew its stake in shares of Omada Health by 0.7% in the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after acquiring an additional 1,791 shares during the last quarter. Quarry LP bought a new position in Omada Health during the fourth quarter worth $29,000. Barclays PLC raised its stake in Omada Health by 14.6% during the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares during the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new position in Omada Health during the 4th quarter valued at $32,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.